AngioDynamics, Inc. (ANGO) Gross margin 2017–2026
AngioDynamics, Inc. (ANGO) gross margin by fiscal year — reported gross profit divided by reported revenue.
54.6%FY2026 · since FY2017: 53.4% → 54.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | 54.6% | +0.7 pp |
| FY2025 | 53.9% | +3.0 pp |
| FY2024 | 50.9% | -0.5 pp |
| FY2023 | 51.4% | -1.0 pp |
| FY2022 | 52.4% | -1.5 pp |
| FY2021 | 53.9% | -3.0 pp |
| FY2020 | 56.9% | -0.8 pp |
| FY2019 | 57.6% | +2.7 pp |
| FY2018 | 55.0% | +1.6 pp |
| FY2017 | 53.4% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ANGO financial trends
ANGO RevenueANGO Net incomeANGO Net marginANGO Gross profitANGO Operating incomeANGO Operating marginANGO Operating cash flowANGO Free cash flowANGO Capital expendituresANGO Return on equityANGO Stock buybacksANGO Dividends paidANGO Total assetsANGO Total liabilitiesANGO Shareholders’ equityANGO overview →